MMWR Morbidity Tables
Data for nationally notifiable diseases reported by the 50 states, New York City, the District of Columbia, and the U.S. territories are collated and published weekly in the Morbidity and Mortality Weekly Report (MMWR). Cases reported by state health departments to CDC for weekly publication are provisional because of ongoing revision of information and delayed reporting.
Case counts in these query tables are presented as they were published in the MMWR issues. Therefore, numbers listed in later MMWR weeks may reflect changes made to these counts as additional information becomes available.
Note that the list of diseases reported in each table, and the table format, vary by year and publication week.
Table I lists provisional cases of infrequently reported notifiable diseases (<1,000 cases reported during the preceding year). Table I shows the number of cases reported for the current week, the cumulative number of cases reported for the current year, the 5 year weekly average, and the total cases reported for each of the previous 5 years. Table I became available in 2007.
Table II lists cases of selected notifiable diseases by location within the United States, and shows the total cases for the current week, and the cumulative total number of cases in the previous 52 weeks.
Table III lists cases of selected notifiable vaccine-preventable diseases by publication week and location within the United States. This table included the following diseases: H. influenzae, invasive; Hepatitis A and B; Measles both indigenous and imported; Meningococcal disease; Mumps; Pertussis; Rubella. Table III is available through year 2001. These conditions are currently reported in tables I (Mumps and Rubella) and II.
Table IV lists quarterly cases of AIDS, HV/AIDS and Tuberculosis by location within the United States, and shows the total cases for the current quarter, and the minimum and maximum number of cases reported for the previous 4 quarters. Table IV became available in year 2007.
The following conditions are included in the nationally notifiable diseases: †
Acquired Immune Deficiency Syndrome (AIDS) 4 Anthrax 1 Botulism: foodborne, infant and other (wound & unspecified) 1 Brucellosis 1 Chlamydia 2 Chancroid 1 Chlamydia 2 Cholera 1 Coccidioidomycosis 2 Cryptosporidiosis 2 Cyclosporiasis 1 Dengue Virus Infection: Dengue Fever, Dengue Hemorrhagic Fever 2 Diphtheria 1 Domestic arboviral diseases: California serogroup, eastern equine, Powassan, St. Louis, western equine 1 Ehrlichiosis/Anaplasmosis: Ehrlichia chaffeensis, Anaplasma phagocytophilum, Undetermined 2 Ehrlichiosis: human granulocytic, human monocytic, human (other & unspecified) 1 Giardiasis 2 Gonorrhea 2 Haemophilus influenzae, invasive, All ages, all serotypes 2 Haemophilus influenzae, invasive disease (age <5 yrs): serotype b, nonserotype b, unknown serotype 1 Hansen disease § 1 Hantavirus pulmonary syndrome § † Hemolytic uremic syndrome, post-diarrheal § 1 Hepatitis (viral, acute), type A, type B 2 Hepatitis C viral, acute 1 HIV/AIDS 4 HIV infection, pediatric (age <13 yrs) 1 Influenza-associated pediatric mortality § 1 Legionellosis 2 Listeriosis 1 Lyme disease 2 Malaria 2 Measles 1 Meningococcal disease, invasive: A, C, Y, and W-135, serogroup B, other serogroup, unknown serogroup 1 Meningococcal diseases, invasive, All serogroups 2 Mumps 1 Novel influenza A infection virus 1 Pertussis 2 Plague 1 Poliomyelitis, paralytic 1 Poliovirus infection, nonparalytic § 1 Psittacosis § 1 Q fever § 1 Rabies: human †, animal 2 Rocky Mountain spotted fever 2 Rubella, and congenital syndrome 1 Salmonellosis 2 SARS CoV § Shiga toxin-producing E. coli(STEC): includes E. coli O157:H7 2 Shigellosis 2 Smallpox § 1 Streptococcal disease, invasive, group A 2 Streptococcus pneumoniae, invasive disease, Age <5 years 2 Streptococcus pneumoniae, invasive disease, drug resistant 2 Streptococcal toxic-shock syndrome § 1 Syphilis, congenital (age <1 yr) †, primary & secondary 2 Tetanus 1 Toxic-shock syndrome (staphylococcal) § 1 Trichinellosis 1 Tuberculosis 4 Tularemia 1 Typhoid fever † Vancomycin-intermediate and Vancomycin-resistant Staphylococcus aureus § 1 Varicella (chickenpox) 2 Vibriosis (non-cholera Vibrio species infections) § 1 West Nile virus disease: Neuroinvasive, Non-neuroinvasive § 2 Yellow fever 1
Notes:† Case counts are provisional and subject to change. Please refer to the footnotes below the tables for more information. Refer to the MMWR publication for weekly updates to the footnotes for various conditions. For further information on interpretation of these data, see http://wwwn.cdc.gov/nndss/document/ProvisionalNationaNotifiableDiseasesSurveillanceData20100927.pdf.
§ Not reportable in all states. Data from states where the condition is not reportable are excluded, except starting in 2007 for the Arboviral diseases, STD data, TB data, and influenza-associated pediatric mortality, and in 2003 for SARS-CoV. Reporting exceptions are available at http://wwwn.cdc.gov/nndss/document/SRCA_FINAL_REPORT_2006-2012_final.xlsx.
1 Infrequently reported conditions are listed in table I. Conditions listed are current as of May 2014.
2 Conditions reported in table II. Conditions listed are current as of May 2014.
3 Selected vaccine preventable diseases were reported in table III through 2001: H. influenzae, invasive; Hepatitis (viral): type A, type B; Measles (Rubeola): Indigenous, Imported, Total; Meningococcal Disease; Mumps; Pertussis; Rubella.
4 Conditions reported quarterly in table IV: AIDs. HIV/AIDS and Tuberculosis since 2007. Conditions listed are current as of May 2014.
See National Notifiable Diseases Surveillance System (NNDSS) for more information.
122 Cities Mortality Tables
As part of its national influenza surveillance effort, CDC receives weekly mortality reports from 122 cities and metropolitan areas in the United States within 2-3 weeks from the date of death. These reports summarize the total number of deaths occurring in these cities/areas each week, as well as the number due to pneumonia and influenza. Data are published weekly in the Morbidity and Mortality Weekly Report (MMWR).